Magnetic based graphene composites with steroidal diamine dimer as potential drug in hyperthermia cancer therapy

被引:3
|
作者
Abskharoun, Sally B. [1 ]
Shawakfeh, Khaled Q. [1 ]
Albiss, Borhan Aldeen A. [2 ]
Alsharaeh, Edreese H. [3 ]
机构
[1] Jordan Univ Sci & Technol, Dept Chem, POB 3030, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Fac Sci & Arts, Dept Appl Phys, Magnet & Nanomat Lab, POB 3030, Irbid 22110, Jordan
[3] Alfaisal Univ, Coll Sci & Gen Studies, POB 50927, Riyadh 11533, Saudi Arabia
关键词
graphene oxide; steroids; magnetite nanoparticles; hyperthermia; anti-cancer agent; IRON-OXIDE NANOPARTICLES; FUNCTIONALIZATION; COMPLEXES; DELIVERY;
D O I
10.1088/2053-1591/abb262
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Hyperthermia is a non-invasive process of killing cells through heat, as cells go into apoptosis when heated in the range of 41 degrees C-47 degrees C. In this work, the biologically active 4-pregnen-3-one-20 beta-carboxaldehyde (ketobisnoraldehyde) based steroidal diamine dimer (KPD) was chemically grafted on GO surface (GO-KPD) for the first time through an amidation reaction between amine groups of KPD and activated carboxylic acid sites of GO. Magnetite nanoparticles (Fe3O4) were dispersed on the prepared nanocomposite surface to produce GO-KPD-Fe(3)O(4)nanocomposite with superparamagnetic property. To study the structural effect of KPD, 1,4 diamonobutane (Putrescine) was also grafted chemically on GO via amidation reaction. Successful functionalization of GO surface was confirmed using Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy, X-ray diffraction (XRD), elemental analysis, and thermogravimetric analysis (TGA). The morphology of the functionalized GO was characterized by scanning electron microscopy (SEM). Furthermore, a cytotoxicity test on Michigan Cancer Foundation-7 (CMF-7) human breast cancer cell line was conducted. The data suggest that the prepared nanocomposite (GO-KPD-Fe3O4) has a cytotoxic potential against the MCF-7 cell line, thus it could be investigated as potential drug in hyperthermia cancer therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Magnetic Gel Composites for Hyperthermia Cancer Therapy
    Haering, Marleen
    Schiller, Jana
    Mayr, Judith
    Grijalvo, Santiago
    Eritja, Ramon
    Diaz Diaz, David
    GELS, 2015, 1 (02) : 135 - 161
  • [2] A smart magnetic nanosystem with controllable drug release and hyperthermia for potential cancer therapy
    Xu, Yi
    Zhu, Yufang
    Kaskel, Stefan
    RSC ADVANCES, 2015, 5 (121): : 99875 - 99883
  • [3] Magnetic nanoparticles for drug delivery and hyperthermia - new chances for cancer therapy
    Alexiou, C.
    Tietze, R.
    Schreiber, E.
    Lyer, S.
    ONKOLOGE, 2011, 17 (05): : 405 - +
  • [4] Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery
    Lucaciu, Constantin Mihai
    PHARMACEUTICS, 2024, 16 (02)
  • [5] Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
    Kumar, Challa S. S. R.
    Mohammad, Faruq
    ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (09) : 789 - 808
  • [6] Nanomedicine: Magnetic nanoparticles for drug delivery and hyperthermia - New chances for cancer therapy
    Alexiou C.
    Tietze R.
    Schreiber E.
    Lyer S.
    Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2010, 53 (8) : 839 - 845
  • [7] Magnetic Fluid Hyperthermia for Cancer Therapy
    Miaskowski, Arkadiusz
    Krawczyk, Andrzej
    PRZEGLAD ELEKTROTECHNICZNY, 2011, 87 (12B): : 125 - 127
  • [8] Fabrication and potential application of a di-functional magnetic system: magnetic hyperthermia therapy and drug delivery
    Shen, B. B.
    Gao, X. C.
    Yu, S. Y.
    Ma, Y.
    Ji, C. H.
    CRYSTENGCOMM, 2016, 18 (07): : 1133 - 1138
  • [9] Advancement in magnetic hyperthermia-based targeted therapy for cancer treatment
    Srivastava, Neha
    Chudasama, Bhupendra
    Baranwal, Manoj
    BIOINTERPHASES, 2022, 18 (06)
  • [10] Cancer Therapy; Prospects for Application of Nanoparticles for Magnetic-Based Hyperthermia
    Rahban, Dariuosh
    Doostan, Mahtab
    Salimi, Ali
    CANCER INVESTIGATION, 2020, 38 (8-9) : 507 - 521